Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

December 1, 2013

Study Completion Date

December 1, 2013

Conditions
Operable Breast Neoplasms
Interventions
DRUG

letrozole (Femara)

tablet 2.5 mg daily

Trial Locations (9)

4100

Depart. of Breast Surgery, Ringsted Sygehus, Ringsted

DK-9000

Dept. of Breast Surgery; Aalborg Sygehus, Aalborg

DK-8000

Dept. of Surgery; Århus Sygehus, Aarhus

DK-2100

Dept. of Breast Surgery; Rigshospitalet, Copenhagen

DK-6700

Dept. of Surgery; Sydvestjysk Sygehus Esbjerg, Esbjerg

DK-2730

Dept. of Breast Surgery; Herlev Hospital, Herlev

DK-5000

Dept. of Oncology; Odense University Hospital, Odense

DK-7100

Dept. of Breast Surgery; Vejle Sygehus, Vejle

DK-8800

Dept. of Breast Surgery; Regionshospitalet Viborg, Viborg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Danish Medical Research Council

OTHER

collaborator

Danish Cancer Society

OTHER

collaborator

Novartis

INDUSTRY

lead

Danish Breast Cancer Cooperative Group

OTHER